SCHEMBL26298665

SCHEMBL26298665

CCCNc1sc2ccccc2c1S

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.39
GPR3 P46089 1/20 0.38
MAPK1 P28482 2/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
APP P05067 3/20 0.36
ABCC1 P33527 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
PDE5A O76074 1/20 0.35
KDM4E B2RXH2 3/20 0.34
ELANE P08246 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TLR7 Q9NYK1 1/20 0.33
OGG1 O15527 1/20 0.33
GAA P10253 1/20 0.33
UTS2R Q9UKP6 1/20 0.33
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33
HTR1B P28222 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19830938 0.77 GPR3 (0.44) IDO1GPR3MAPK1SMN1; SMN2ABCC1
SCHEMBL11558126 0.68 MAPK1 (0.42) IDO1GPR3MAPK1HTTSMN1; SMN2
Dibenzothiophene SCHEMBL232234 0.67 GPR3 (0.74) GPR3MAPK1SMN1; SMN2KDM4EALDH1A1
SCHEMBL14619935 0.66 GPR3 (0.50) GPR3MAPK1SMN1; SMN2KDM4EALDH1A1
SCHEMBL17973603 0.66 MCL1 (0.50) MAPK1HTTSMN1; SMN2KDM4EALDH1A1
SCHEMBL26737371 0.65 GPR3 (0.55) IDO1GPR3MAPK1SMN1; SMN2KDM4E
SCHEMBL5713472 0.65 IDO1 (0.44) IDO1HTTSMN1; SMN2APPKDM4E
SCHEMBL28600336 0.65 MCL1 (0.49) MAPK1HTTSMN1; SMN2KDM4EALDH1A1
Dibenzothiophene SCHEMBL8388551 0.65 GPR3 (0.78) GPR3MAPK1SMN1; SMN2KDM4EALDH1A1
Lithium Ion SCHEMBL17960492 0.64 LIMK1 (0.47) MAPK1HTTSMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230276696-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORP (US) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230276696-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, PORCN IDO1 1544/4885GPR3 2221/4885MAPK1 2100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.